Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Año de publicación
2021
Autores
Cabezon, M; Malinverni, R; Bargay, J; Xicoy, B; Marce, S; Garrido, A; Tormo, M; Arenillas, L; Coll, R; Borras, J; Jimenez, MJ; Hoyos, M; Valcarcel, D; Escoda, L; Vall-Llovera, F; Garcia, A; Font, LL; Ramila, E; Buschbeck, M; Zamora, L
Grupo de Trabajo
Revista
CLINICAL EPIGENETICS
Volumen
13
Article number
9
Issue
1